|
|
Economy class animal blue fox bile for TLC identification and its protection against CCL4 hepatic injury |
ZHOU Bo1, JIA Jingbo2, LI Jiaming3 |
1.College of Wildlife Resource, Northeast Forestry University, Harbin 150050,China; 2.Traditional Chinese Medicine Resources Development and Utilization, College of Pharmacy Heilongjiang University of Chinese Medicine, Harbin 150001,China; 3.Department of Orthopedics the Fifth Hospital in Harbin City of Heilongjiang, Harbin 150051,China |
|
|
Abstract Objective To determine the pharmacological effects of blue fox bile. Method Thirty Kunming mice were divided into 5 groups, each group of six. (1)For the blank group, without the liver damage treatment, was fed on distilled water, and harmless soybean oil was injected. (2) For the model group with liver damage, no drugs were given, were completely CCL4 acute liver injury individuals. (3) For positive group with liver damage were fed on liver-protecting, 0.4/kg. (4) For the high dose group with liver damage was fed on high dose of blue fox bile powder, 10 g/kg. (5) For the low dose group with liver damage was fed on the low dose of blue fox bile powder, 5 g/kg. The first study was using TLC method, to determine whether the blue fox bile contained ursodeoxy cholic acid (UDCA). The second study was to determine whether the blue fox bile has a protective effect on CCL4 caused hepatic injury in mice. Results The similarity between blue fox bile and bear bile is about 50%, both with two kinds of material, the same in the four kinds of material. Blue fox UDCA component is contained in bile. After experimental animals were inflicted on injury of the liver by CCL4, AST and ALT in serum concentration significantly increased; the difference between the model group and the blank group was statistically significant. Through pharmacological results and pharmacological slices, it can be seen that CCL4 caused AST, ALT concentration effect acute liver injury can be inhibited in mice. Conclusions Blue fox bile can repair injury of liver cells and has obvious protective effects on the liver.
|
Received: 03 March 2015
|
|
|
|
|
[1] |
白玉妍,刘思宇,唐 澜,等. 微卫星DNA标记在蓝狐单亲亲权中的应用[J]. 经济动物学报,2010, 3(1):78-79.
|
[2] |
薛 毅.狐胆汁对蟾蜍离体心脏功能的影响[J].野生动物,2012,32(4):217-220.
|
[2] |
薛 毅.狐胆汁对蟾蜍离体心脏功能的影响[J].野生动物,2012,32(4):217-220.
|
[3] |
Hagey L R, Crombie D L, Espinosa E, et al. Ursodeoxycholic acid in the Ursidae: biliary bile acids of bears, pandas, and related carnivores[J]. Lipid Res, 1993, 34:1911-1917
|
[3] |
Hagey L R, Crombie D L, Espinosa E, et al. Ursodeoxycholic acid in the Ursidae: biliary bile acids of bears, pandas, and related carnivores[J]. Lipid Res, 1993, 34:1911-1917
|
[4] |
乔俊文,赵 德. 3种肝损伤模型的组织病理学特征观察[J]. 中国兽医杂志,2007,43(10):11-12.
|
[4] |
乔俊文,赵 德. 3种肝损伤模型的组织病理学特征观察[J]. 中国兽医杂志,2007,43(10):11-12.
|
[5] |
鞠玲卉. 中成药制剂治疗肝硬化的品种分析[J]. 亚太传统医药,2009,5(1):106-107.
|
[5] |
鞠玲卉. 中成药制剂治疗肝硬化的品种分析[J]. 亚太传统医药,2009,5(1):106-107.
|
[6] |
Weber L W, Boll M, Stampfl A. Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model[J].Crit Rev Toxicol,2003,33:105-136.
|
[6] |
Weber L W, Boll M, Stampfl A. Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model[J].Crit Rev Toxicol,2003,33:105-136.
|
[7] |
梁道明,胡智兴. 不同剂量CCL4急性肝损伤模型的评价[J]. 重庆医学,2010,43(1):18-20.
|
[7] |
梁道明,胡智兴. 不同剂量CCL4急性肝损伤模型的评价[J]. 重庆医学,2010,43(1):18-20.
|
[8] |
俞 渊,唐乾利,郝 军. 慢性肝损伤家兔胆石症模型制作及成石因素研究[J]. 中国医药导报,2007,34(4):106-108.
|
[9] |
杨剑虹,邬 明,陆卫华,等.Wistar大鼠枯否细胞的分离、鉴定与培养[J].华南国防医学杂志,2014,28(7):627-638.
|
[10] |
辛华雯,刘慧明,李元启,等.ABCB1基因多态性与肾移植受者环孢素所致肝功能异常的相关性研究[J].华南国防医学杂志,2013,27(1):17-20.
|
[8] |
俞 渊,唐乾利,郝 军. 慢性肝损伤家兔胆石症模型制作及成石因素研究[J]. 中国医药导报,2007,34(4):106-108.
|
[9] |
杨剑虹,邬 明,陆卫华,等.Wistar大鼠枯否细胞的分离、鉴定与培养[J].华南国防医学杂志,2014,28(7):627-638.
|
[10] |
辛华雯,刘慧明,李元启,等.ABCB1基因多态性与肾移植受者环孢素所致肝功能异常的相关性研究[J].华南国防医学杂志,2013,27(1):17-20.
|
|
|
|